Clinitech Laboratory Past Earnings Performance
Past criteria checks 2/6
Clinitech Laboratory has been growing earnings at an average annual rate of 0.9%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 16.9% per year. Clinitech Laboratory's return on equity is 5.5%, and it has net margins of 7%.
Key information
0.9%
Earnings growth rate
-25.3%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 16.9% |
| Return on equity | 5.5% |
| Net Margin | 7.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Clinitech Laboratory makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 75 | 5 | 25 | 0 |
| 30 Jun 24 | 69 | 4 | 24 | 0 |
| 31 Mar 24 | 64 | 4 | 23 | 0 |
| 31 Mar 23 | 63 | 6 | 20 | 0 |
| 31 Mar 22 | 64 | 5 | 18 | 0 |
| 31 Mar 21 | 46 | 4 | 12 | 0 |
Quality Earnings: 544220 has a high level of non-cash earnings.
Growing Profit Margin: 544220's current net profit margins (7%) are lower than last year (7.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 544220's earnings have grown by 0.9% per year over the past 5 years.
Accelerating Growth: 544220's earnings growth over the past year (6.6%) exceeds its 5-year average (0.9% per year).
Earnings vs Industry: 544220 earnings growth over the past year (6.6%) did not outperform the Healthcare industry 33.2%.
Return on Equity
High ROE: 544220's Return on Equity (5.5%) is considered low.